Your support of Gabrielle’s Angel Foundation allows us to push the boundaries of what is scientifically possible for those living with blood cancer. Meet the dedicated research scientists whose cutting-edge ideas are giving patients reason to hope and hear all about their latest breakthroughs below!
Big news from Dana-Farber Cancer Institute regarding the FDA approval of revumenib for the treatment of relapsed acute leukemia! Gabrielle’s Angel Foundation funded Scott Armstrong, MD, PhD...
After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of...
Exciting news out of Dana-Farber on a the development of new menin-targeting agents that showed promise in clinical trials involving adults with acute myeloid leukemia (AML), one of the...
With your support in 2023, we were able to fund 6 new individual researchers with grants of $225,000 each as well as co-funding with The Mark Foundation for Cancer Research 2 new collaborative...
Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are...
We are delighted to welcome Dr. Sarah Tasian to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research! Sarah K Tasian, MD is a pediatric oncologist and physician-scientist...
From the lab of Gabrielle’s Angels grantee Iannis Aifantis – their latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially...
We are thrilled to announce that we have selected the recipients of our first ever Mark Foundation – Gabrielle’s Angel Foundation Collaborative Grants. Co-funded with...
Congratulations to Zuzana Tothova, MD, PhD (Gabrielle’s Angels Grantee 2022) who is the recipient of the Doris Duke Foundation‘s Paragon Award for Research Excellence! This one-time...
A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The...
Daniel Herranz Benito, an associate professor in the Department of Pharmacology, recently received an $800,000 grant from the V Foundation for Cancer Research to further research T cell Acute...